NCT02418845View on ClinicalTrials.gov

A Phase 3 Study of SYM-1219 Treatment of Women and Post-Menarchal Adolescent Girls With Bacterial Vaginosis

PHASE3CompletedINTERVENTIONAL
Enrollment

189

Participants

Timeline

Start Date

May 28, 2015

Primary Completion Date

October 5, 2015

Study Completion Date

December 5, 2015

Conditions
Bacterial Vaginosis
Interventions
DRUG

SYM-1219

DRUG

Placebo

Trial Locations (21)

19107

Philadelphia

19114

Philadelphia

21224

Baltimore

23456

Virginia Beach

28562

New Bern

29572

Myrtle Beach

30312

Atlanta

33161

Miami

33414

Wellington

34748

Leesburg

35294

Birmingham

49503

Grand Rapids

72401

Jonesboro

73212

Columbus

77054

Houston

78414

Corpus Christi

80209

Denver

80910

Colorado Springs

92108

San Diego

98105

Seattle

08536

Plainsboro

Sponsors
All Listed Sponsors
lead

Symbiomix Therapeutics

INDUSTRY